Condensed Consolidated Balance Sheets (Unaudited) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
CURRENT ASSETS:
Cash and cash equivalents	$ 107,643	$ 100,922
Accounts receivable, net	270,851	263,970
Inventory	4,062,827	4,013,525
Marketable securities related party	9,504	14,933
Prepaid expenses and other current assets	192,133	263,003
TOTAL CURRENT ASSETS	4,642,958	4,656,353
Operating lease right-of-use asset, net, related party	3,685,567	3,864,591
Property and equipment, net	6,069,570	6,448,068
Intangible assets, net
Goodwill	3,014,450	3,014,450
TOTAL ASSETS	17,412,545	17,983,462
CURRENT LIABILITIES:
Accounts payable and accrued expenses	5,178,214	4,629,591
Operating lease liability, current portion, related party	3,055,134	2,913,781
Convertible note payable, net		115,000
Paycheck protection loan, SBA Loan	99,100	99,100
TOTAL CURRENT LIABILITIES:	20,391,818	19,448,031
Operating lease liability, long-term portion, related party	3,070,391	3,254,021
Other long-term liabilities, related party	3,572,864	3,572,864
TOTAL LIABILITIES	27,035,073	26,274,916
Commitments and contingencies
STOCKHOLDERS’ EQUITY
Common Stock: $0.0001 Par Value, 650,000,000 shares authorized; 18,311,352 and 17,645,352 shares issued and outstanding on March 31, 2024 and December 31, 2023 respectively.	1,832	1,765
Additional paid in capital	25,743,375	25,628,442
Accumulated deficit	(35,368,972)	(33,922,898)
TOTAL STOCKHOLDERS’ EQUITY	(9,622,528)	(8,291,454)
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	17,412,545	17,983,462
Series A Preferred Stock [Member]
STOCKHOLDERS’ EQUITY
Series E Preferred: $0.0001 Par Value, 3,853,000 shares designated and 3,853,000 and 3,853,000 shares issued and outstanding on March 31, 2024 and December 31, 2023 respectively.
Series B-1 Preferred Stock [Member]
STOCKHOLDERS’ EQUITY
Series E Preferred: $0.0001 Par Value, 3,853,000 shares designated and 3,853,000 and 3,853,000 shares issued and outstanding on March 31, 2024 and December 31, 2023 respectively.	150	150
Series B-2 Preferred Stock [Member]
STOCKHOLDERS’ EQUITY
Series E Preferred: $0.0001 Par Value, 3,853,000 shares designated and 3,853,000 and 3,853,000 shares issued and outstanding on March 31, 2024 and December 31, 2023 respectively.	600	600
Series C Preferred Stock [Member]
STOCKHOLDERS’ EQUITY
Series E Preferred: $0.0001 Par Value, 3,853,000 shares designated and 3,853,000 and 3,853,000 shares issued and outstanding on March 31, 2024 and December 31, 2023 respectively.	100	100
Series C-1 Preferred Stock [Member]
STOCKHOLDERS’ EQUITY
Series E Preferred: $0.0001 Par Value, 3,853,000 shares designated and 3,853,000 and 3,853,000 shares issued and outstanding on March 31, 2024 and December 31, 2023 respectively.	1	1
Series C-2 preferred stock [Member]
STOCKHOLDERS’ EQUITY
Series E Preferred: $0.0001 Par Value, 3,853,000 shares designated and 3,853,000 and 3,853,000 shares issued and outstanding on March 31, 2024 and December 31, 2023 respectively.
Series D Preferred Stock [Member]
STOCKHOLDERS’ EQUITY
Series E Preferred: $0.0001 Par Value, 3,853,000 shares designated and 3,853,000 and 3,853,000 shares issued and outstanding on March 31, 2024 and December 31, 2023 respectively.	1	1
Series E Preferred Stock [Member]
STOCKHOLDERS’ EQUITY
Series E Preferred: $0.0001 Par Value, 3,853,000 shares designated and 3,853,000 and 3,853,000 shares issued and outstanding on March 31, 2024 and December 31, 2023 respectively.	385	385
Related Party [Member]
CURRENT ASSETS:
Other receivables, related party
CURRENT LIABILITIES:
First Bank note payable	11,772,259	11,397,617
Nonrelated Party [Member]
CURRENT LIABILITIES:
First Bank note payable	$ 287,111	$ 292,942

PANACEA LIFE SCIENCES HOLDINGS, INC. 10-Q